ID

32730

Beschreibung

Study ID: 109059 Clinical Study ID: OTB109059 Study Title: TXA107979:A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01021553 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: epelsiban Trade Name: Study Indication: Premature Ejaculation

Stichworte

  1. 13.11.18 13.11.18 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

13. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Delay in IELT, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK557296 in Men with Premature Ejaculation, 109059

PGx-Pharmacogenetic Research Consent

PGx-Pharmacogenetic Research Consent
Beschreibung

PGx-Pharmacogenetic Research Consent

Alias
UMLS CUI-1
C2347500
UMLS CUI-2
C0021430
Has informed consent been obtained for PGx- Pharmacogenetic research?
Beschreibung

Pharmacogenetic Test, Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C0021430
Date informed consent obtained for PGx-Pharmacogenetic research
Beschreibung

Pharmacogenetic Test, Informed Consent, Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C0011008
No informed consent for PGx- Pharmacogenetic research obtained - Reason
Beschreibung

Pharmacogenetic Test, Informed Consent, Indication

Datentyp

text

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C0392360
Has a blood sample been collected for PGx-pharmacogenetic (DNA) research?
Beschreibung

Pharmacogenetic Test, Collection of blood specimen for laboratory procedure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0005834
Date sample taken
Beschreibung

Pharmacogenetic Test, Collection of blood specimen for laboratory procedure, Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C0031325
UMLS CUI [1,2]
C0005834
UMLS CUI [1,3]
C0011008
Withdrawal of Consent for PGx (DNA) Sample Destruction
Beschreibung

Withdrawal of Consent for PGx (DNA) Sample Destruction

Alias
UMLS CUI-1
C0444245
UMLS CUI-2
C1948029
UMLS CUI-3
C1707492
Has subject withdrawn consent for PGx research?
Beschreibung

Pharmacogenetic Test, Consent withdrawn

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C1707492
Date informed consent withdrawn
Beschreibung

Pharmacogenetic Test, Consent withdrawn, Date in time

Datentyp

date

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C1707492
UMLS CUI [1,3]
C0011008
Has a request been made for sample destruction?
Beschreibung

DNA sample, Destruction, Request

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0444245
UMLS CUI [1,2]
C1948029
UMLS CUI [1,3]
C1272683
Has a request been made for sample destruction? - Reason
Beschreibung

DNA sample, Destruction, Request, Indication

Datentyp

text

Alias
UMLS CUI [1,1]
C0444245
UMLS CUI [1,2]
C1948029
UMLS CUI [1,3]
C1272683
UMLS CUI [1,4]
C0392360

Ähnliche Modelle

PGx-Pharmacogenetic Research Consent

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
PGx-Pharmacogenetic Research Consent
C2347500 (UMLS CUI-1)
C0021430 (UMLS CUI-2)
Pharmacogenetic Test, Informed Consent
Item
Has informed consent been obtained for PGx- Pharmacogenetic research?
boolean
C2347500 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Pharmacogenetic Test, Informed Consent, Date in time
Item
Date informed consent obtained for PGx-Pharmacogenetic research
date
C2347500 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
No informed consent for PGx- Pharmacogenetic research obtained - Reason
text
C0031325 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Code List
No informed consent for PGx- Pharmacogenetic research obtained - Reason
CL Item
Subject declined (Subject declined)
CL Item
Subject not asked by Investigator (Subject not asked by Investigator)
CL Item
Other (Other)
Pharmacogenetic Test, Collection of blood specimen for laboratory procedure
Item
Has a blood sample been collected for PGx-pharmacogenetic (DNA) research?
boolean
C0031325 (UMLS CUI [1,1])
C0005834 (UMLS CUI [1,2])
Pharmacogenetic Test, Collection of blood specimen for laboratory procedure, Date in time
Item
Date sample taken
date
C0031325 (UMLS CUI [1,1])
C0005834 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item Group
Withdrawal of Consent for PGx (DNA) Sample Destruction
C0444245 (UMLS CUI-1)
C1948029 (UMLS CUI-2)
C1707492 (UMLS CUI-3)
Pharmacogenetic Test, Consent withdrawn
Item
Has subject withdrawn consent for PGx research?
boolean
C2347500 (UMLS CUI [1,1])
C1707492 (UMLS CUI [1,2])
Pharmacogenetic Test, Consent withdrawn, Date in time
Item
Date informed consent withdrawn
date
C2347500 (UMLS CUI [1,1])
C1707492 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
DNA sample, Destruction, Request
Item
Has a request been made for sample destruction?
boolean
C0444245 (UMLS CUI [1,1])
C1948029 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
Item
Has a request been made for sample destruction? - Reason
text
C0444245 (UMLS CUI [1,1])
C1948029 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
C0392360 (UMLS CUI [1,4])
Code List
Has a request been made for sample destruction? - Reason
CL Item
Subject withdrew consent for PGx (Subject withdrew consent for PGx)
CL Item
Screen failure (Screen failure)
CL Item
Other (Other)

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video